Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
73,039,333
Number of holders
58
Total 13F shares, excl. options
34,630,744
Shares change
+1,399,992
Total reported value, excl. options
$423,528,800
Value change
+$16,981,526
Number of buys
37
Number of sells
-14
Price
$12.23

Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q2 2022

61 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 34,630,744 shares of 73,039,333 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include venBio Partners LLC (5,011,536 shares), Third Point LLC (4,312,834 shares), CITADEL ADVISORS LLC (3,891,328 shares), Logos Global Management LP (2,312,680 shares), Vivo Capital, LLC (1,921,726 shares), JANUS HENDERSON GROUP PLC (1,905,247 shares), FMR LLC (1,575,942 shares), RTW INVESTMENTS, LP (1,551,778 shares), EcoR1 Capital, LLC (1,300,000 shares), and ORBIMED ADVISORS LLC (1,289,280 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.